These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7062406)

  • 1. Salmonella Minnesota Re 595 lipid A induced nephritis.
    Hemstreet GP; Brown AL; Fine PR; Molay MP; Wheat R
    J Urol; 1982 Feb; 127(2):374-8. PubMed ID: 7062406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid A induction of cytotoxic antibody to cultured syngeneic rat kidney tubular cells.
    Hemstreet GP; Enoch PG; Fine PR; Wheat R
    Kidney Int; 1981 Feb; 19(2):275-80. PubMed ID: 7230615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auto-antibody to kidney tubular cells during retrograde chronic pyelonephritis in rats.
    Feye GL; Hemstreet GP; Klingensmith C; Cruse JM; Lewis RE; Anderson IC
    Nephron; 1985; 39(4):371-6. PubMed ID: 3885065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial lipopolysaccharide and its lipid A component: some historical and some current aspects.
    Westphal O; Lüderitz O; Rietschel ET; Galanos C
    Biochem Soc Trans; 1981 Jun; 9(3):191-5. PubMed ID: 7274542
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoclonal antibodies to salmonella lipopolysaccharide: functional analysis of anti-lipid A antibodies.
    Ward DC; Michalek SM; McGhee JR
    Clin Exp Immunol; 1988 Apr; 72(1):157-63. PubMed ID: 3293850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A direct enzyme-linked immunosorbent assay (ELISA) for antibodies to enterobacterial Re core glycolipid and lipid A. Results in healthy subjects and in patients infected by gram-negative bacteria.
    Nys M; Damas P; Damas F; Joassin L; Demonty J
    Med Microbiol Immunol; 1987; 176(5):257-71. PubMed ID: 3657701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimentally induced chronic pyelonephritis using bacterial antigen and its prevention with immunosuppression.
    Strong DW; Lawson RK; Hodges CV
    Invest Urol; 1974 May; 11(6):479-85. PubMed ID: 4597433
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon-inducing activity of Salmonella minnesota re glycolipid--anti-glycolipid immune complexes.
    Eskenazy M; Galabov AS; Mastikova M; Konstantinov G; Tekelieva R
    Acta Virol; 1983 Jan; 27(1):83-5. PubMed ID: 6133436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The primary B cell response to the O/core region of bacterial lipopolysaccharide is restricted to the Ly-1 lineage.
    Su SD; Ward MM; Apicella MA; Ward RE
    J Immunol; 1991 Jan; 146(1):327-31. PubMed ID: 1701797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation by bacterial surface glycolipids: a study with planar bilayer membranes.
    Münstermann M; Wiese A; Brandenburg K; Zähringer U; Brade L; Kawahara K; Seydel U
    J Membr Biol; 1999 Feb; 167(3):223-32. PubMed ID: 9929374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of O-antigen polysaccharide in the activation of neutrophils by lipopolysaccharides of Salmonella species.
    Rasool O; Nnalue NA; Jarstrand C
    Clin Exp Immunol; 1992 Oct; 90(1):63-7. PubMed ID: 1382904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the fine specificity and cross-reactivity of monoclonal anti-lipid A antibodies.
    Kirkland TN; Colwell DE; Michalek SM; McGhee JR; Ziegler EJ
    J Immunol; 1986 Dec; 137(11):3614-9. PubMed ID: 2431039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of immunization with Salmonella minnesota Re 595 against ascending Escherichia coli O6K13H1 pyelonephritis in rats.
    Larsson P; Kaijser B; Baltzer IM; Olling S
    Scand J Infect Dis Suppl; 1980; Suppl 24():220-3. PubMed ID: 7010560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins.
    Westphal O; Jann K; Himmelspach K
    Prog Allergy; 1983; 33():9-39. PubMed ID: 6187018
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lipoid A, a factor in the pathogenesis of chronic pyelonephritis. Experimental and clinical studies of a lipoid A dependent pathological immune reaction].
    Westenfelder M
    Fortschr Med; 1979 Feb; 97(6):245-8. PubMed ID: 372074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunologic aspects of experimental pyelonephritis in rats].
    Tuan H; Hagemann I; Dutz W; Briedigkeit H
    Z Urol Nephrol; 1972 Apr; 65(4):259-70. PubMed ID: 4559230
    [No Abstract]   [Full Text] [Related]  

  • 18. Bacterial virulence factors--with particular reference to Salmonella bacteria.
    Lindberg AA
    Scand J Infect Dis Suppl; 1980; Suppl 24():86-92. PubMed ID: 6111123
    [No Abstract]   [Full Text] [Related]  

  • 19. Protective effects of polyclonal sera and of monoclonal antibodies active to Salmonella minnesota Re595 lipopolysaccharide during experimental endotoxemia.
    Nys M; Cloes JM; Demonty J; Joassin L
    J Infect Dis; 1990 Nov; 162(5):1087-95. PubMed ID: 1700024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of oligosaccharide-binding monoclonal antibodies of diverse specificities by immunization with purified tumor-associated glycolipids inserted into liposomes with lipid A.
    Brodin T; Thurin J; Strömberg N; Karlsson KA; Sjögren HO
    Eur J Immunol; 1986 Aug; 16(8):951-6. PubMed ID: 3743633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.